Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Genetic Characterization of Short Stature Patients With Overlapping Features of Growth Hormone Insensitivity Syndromes (CROSBI ID 324855)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Andrews, Afiya ; Maharaj, Avinaash ; Cottrell, Emily ; Chatterjee, Sumana ; Shah, Pratik ; Denvir, Louise ; Dumic, Katja ; Bossowski, Artur ; Mushtaq, Talat ; Vukovic, Rade et al. Genetic Characterization of Short Stature Patients With Overlapping Features of Growth Hormone Insensitivity Syndromes // The Journal of clinical endocrinology and metabolism, 106 (2021), 11; 4716-4733. doi: 10.1210/clinem/dgab437

Podaci o odgovornosti

Andrews, Afiya ; Maharaj, Avinaash ; Cottrell, Emily ; Chatterjee, Sumana ; Shah, Pratik ; Denvir, Louise ; Dumic, Katja ; Bossowski, Artur ; Mushtaq, Talat ; Vukovic, Rade ; Didi, Mohamed ; Shaw, Nick ; Metherell, Louise A ; Savage, Martin O ; Storr, Helen L

engleski

Genetic Characterization of Short Stature Patients With Overlapping Features of Growth Hormone Insensitivity Syndromes

Context Growth hormone insensitivity (GHI) in children is characterized by short stature, functional insulin-like growth factor (IGF)-I deficiency, and normal or elevated serum growth hormone (GH) concentrations. The clinical and genetic etiology of GHI is expanding. Objective We undertook genetic characterization of short stature patients referred with suspected GHI and features which overlapped with known GH–IGF-I axis defects. Methods Between 2008 and 2020, our center received 149 GHI referrals for genetic testing. Genetic analysis utilized a combination of candidate gene sequencing, whole exome sequencing, array comparative genomic hybridization, and a targeted whole genome short stature gene panel. Results Genetic diagnoses were identified in 80/149 subjects (54%) with 45/80 (56%) having known GH– IGF-I axis defects (GHR n = 40, IGFALS n = 4, IGFIR n = 1). The remaining 35/80 (44%) had diagnoses of 3M syndrome (n = 10) (OBSL1 n = 7, CUL7 n = 2, and CCDC8 n = 1), Noonan syndrome (n = 4) (PTPN11 n = 2, SOS1 n = 1, and SOS2 n = 1), Silver–Russell syndrome (n = 2) (loss of methylation on chromosome 11p15 and uniparental disomy for chromosome 7), Class 3-5 copy number variations (n = 10), and disorders not previously associated with GHI (n = 9) (Barth syndrome, autoimmune lymphoproliferative syndrome, microcephalic osteodysplastic primordial dwarfism type II, achondroplasia, glycogen storage disease type IXb, lysinuric protein intolerance, multiminicore disease, macrocephaly, alopecia, cutis laxa, and scoliosis syndrome, and Bloom syndrome). Conclusion We report the wide range of diagnoses in 149 patients referred with suspected GHI, which emphasizes the need to recognize GHI as a spectrum of clinical entities in undiagnosed short stature patients. Detailed clinical and genetic assessment may identify a diagnosis and inform clinical management.

Growth hormone insensitivity (GHI) ; short stature ; overlapping disorders ; genetic

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

106 (11)

2021.

4716-4733

objavljeno

0021-972X

1945-7197

10.1210/clinem/dgab437

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost